Free database of papers and journals






Results 1 to 5 of 5 articles found
2012

Tadalafil and Pulmonary Arterial Hypertension

Clinical Therapeutics (2.3 134), 34, 257.
2011

Tadalafil: A Long-Acting Phosphodiesterase-5 Inhibitor for the Treatment of Pulmonary Arterial Hypertension

Clinical Therapeutics (2.3 134), 33, 993-1004.
2019

A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects

Clinical Therapeutics (2.3 134), 41, 1110-1127.
2003

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction

Clinical Therapeutics (2.3 134), 25, 2709-2723.
2003

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: Results of a European multicenter, open-label study of patient preference

Clinical Therapeutics (2.3 134), 25, 2724-2737.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions